Home › Trial NCT06842498
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Trial IDNCT06842498
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorKyntra Bio
- Enrollment75
- Start date2026-02-22
- ConditionsMetastatic Castration-Resistant Prostate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.